BELLINI, Tiziana
 Distribuzione geografica
Continente #
NA - Nord America 12.523
AS - Asia 6.538
EU - Europa 4.573
SA - Sud America 1.067
AF - Africa 119
OC - Oceania 18
Continente sconosciuto - Info sul continente non disponibili 13
Totale 24.851
Nazione #
US - Stati Uniti d'America 12.285
SG - Singapore 2.547
CN - Cina 2.013
IT - Italia 999
BR - Brasile 904
UA - Ucraina 795
DE - Germania 753
HK - Hong Kong 669
TR - Turchia 525
GB - Regno Unito 431
PL - Polonia 392
VN - Vietnam 336
FI - Finlandia 293
RU - Federazione Russa 229
SE - Svezia 221
CA - Canada 111
MX - Messico 105
ID - Indonesia 93
FR - Francia 90
IN - India 75
AR - Argentina 74
NL - Olanda 68
ZA - Sudafrica 60
BE - Belgio 49
JP - Giappone 49
BD - Bangladesh 41
AT - Austria 39
CZ - Repubblica Ceca 38
EE - Estonia 36
ES - Italia 36
IQ - Iraq 31
LT - Lituania 22
EC - Ecuador 21
IR - Iran 19
CO - Colombia 17
KR - Corea 17
AU - Australia 14
UZ - Uzbekistan 14
PK - Pakistan 13
MY - Malesia 12
AE - Emirati Arabi Uniti 11
BG - Bulgaria 11
MA - Marocco 11
PY - Paraguay 11
SA - Arabia Saudita 11
CL - Cile 10
EG - Egitto 10
RO - Romania 10
UY - Uruguay 10
VE - Venezuela 10
EU - Europa 9
SD - Sudan 9
IE - Irlanda 8
PE - Perù 8
AZ - Azerbaigian 7
IL - Israele 7
JM - Giamaica 7
KE - Kenya 6
NP - Nepal 6
TW - Taiwan 6
DK - Danimarca 5
DZ - Algeria 5
ET - Etiopia 5
PH - Filippine 5
PT - Portogallo 5
RS - Serbia 5
TN - Tunisia 5
A2 - ???statistics.table.value.countryCode.A2??? 4
AL - Albania 4
GE - Georgia 4
GR - Grecia 4
KW - Kuwait 4
KZ - Kazakistan 4
LV - Lettonia 4
MD - Moldavia 4
OM - Oman 4
SI - Slovenia 4
SK - Slovacchia (Repubblica Slovacca) 4
AO - Angola 3
BY - Bielorussia 3
CH - Svizzera 3
NZ - Nuova Zelanda 3
TT - Trinidad e Tobago 3
BA - Bosnia-Erzegovina 2
BB - Barbados 2
BO - Bolivia 2
GD - Grenada 2
HR - Croazia 2
HU - Ungheria 2
JO - Giordania 2
LB - Libano 2
MK - Macedonia 2
NI - Nicaragua 2
PA - Panama 2
QA - Qatar 2
TH - Thailandia 2
AF - Afghanistan, Repubblica islamica di 1
AM - Armenia 1
BH - Bahrain 1
BN - Brunei Darussalam 1
Totale 24.838
Città #
Singapore 1.443
Woodbridge 1.184
Ashburn 1.053
Fairfield 986
Chandler 927
Jacksonville 883
Houston 707
Ann Arbor 684
Beijing 679
Hong Kong 662
Santa Clara 662
Wilmington 409
Warsaw 377
Seattle 361
Izmir 311
Dallas 310
Cambridge 299
Nanjing 255
Ferrara 235
Princeton 207
Los Angeles 191
Munich 185
Boardman 165
Dearborn 123
Milan 113
Ho Chi Minh City 110
New York 106
Nanchang 95
Shenyang 87
Shanghai 85
San Diego 77
São Paulo 75
Addison 74
Mexico City 69
Turku 66
Changsha 65
Hanoi 65
Tianjin 63
Jakarta 62
London 60
Bologna 55
Helsinki 53
Hebei 52
Bremen 50
Brussels 47
Jiaxing 46
Buffalo 45
Hefei 45
Brooklyn 43
Tokyo 42
Rome 41
Chicago 40
Moscow 40
Jinan 36
Toronto 35
Brno 33
Norwalk 33
Montreal 32
Orange 32
Ningbo 31
Orem 31
Phoenix 31
Chennai 30
Johannesburg 30
Boston 29
San Francisco 29
Vienna 28
Poplar 27
Stockholm 27
Curitiba 26
Rio de Janeiro 26
Denver 25
Redwood City 25
Guangzhou 24
Frankfurt am Main 23
Kunming 22
Mountain View 21
Auburn Hills 20
Leawood 20
Atlanta 19
Augusta 19
Zhengzhou 19
Belo Horizonte 18
Düsseldorf 18
Haiphong 18
San Mateo 18
Dong Ket 17
Manchester 17
Ankara 16
Falkenstein 16
Falls Church 16
The Dalles 16
Charlotte 14
Brasília 13
Des Moines 13
Amsterdam 12
Campinas 12
Da Nang 12
Washington 12
Hải Dương 11
Totale 16.221
Nome #
Epstein-Barr Virus Specific Antibody Response in Multiple Sclerosis Patients during 21 Months of Natalizumab Treatment 387
Serum paraoxonase and arylesterase activities of paraoxonase-1 (PON-1), mild cognitive impairment, and 2-year conversion to dementia: A pilot study 254
Balanced and unbalanced solutions modulate the release of Matrix Metalloproteinase-9 (MMP-9) from neutrophils in response to inflammatory stimuli: an in vitro study. 231
Decreased Arylesterase activity of Paraoxonase-1 (PON-1) might be a common denominator of neuroinflammatory and neurodegenerative diseases 225
Evaluation of total, ceruloplasmin-associated and type II ferroxidase activities in serum and cerebrospinal fluid of multiple sclerosis patients 214
TIMP-1 resistant matrix metalloproteinase-9 is the predominant serum active isoform associated with MRI activity in patients with multiple sclerosis 209
Timing of serum active MMP-9 and MMP-2 levels in acute and subacute phases after spontaneous intracerebral hemorrhage 203
“Bridging the Gap” Everything that Could Have Been Avoided If We Had Applied Gender Medicine, Pharmacogenetics and Personalized Medicine in the Gender-Omics and Sex-Omics Era 200
A rapid method for purification of myelin basic protein 196
Antiglaucoma drops influence the production of advanced glycation end-products (AGEs) in the conjunctival sac fluid of glaucoma patients 195
Leishmania Infantum Cryptic Infection in Immunosuppressed Rheumatologic Patients and Healthy Controls from Northern Italy: Epidemiological Variables That Can Affect Infection Risk 194
Mutual relationship between serum ferroxidase activity and hemoglobin levels in elderly individuals 190
Antiprotozoal activity of 6-aminonicotinamide against Leishmania infantum promastigotes 186
Epstein-Barr virus-specific intrathecal oligoclonal IgG production in relapsing-remitting multiple sclerosis is limited to a subset of patients and is composed of low-affinity antibodies 185
Activation of the sendai virus fusion protein by receptor binding 179
Evaluation of a possible role of oxidative stress in climacteric symptoms. 179
Matrix metalloproteinase 9 as a marker of disease activity in multiple sclerosis 177
Subclinical Leishmania infection in patients with rheumatic diseases under biological drugs 177
Chimica Medica e propedeutica Biochimica 176
Interplay between Matrix Metalloproteinase-9, Matrix Metalloproteinase-2, and Interleukins in Multiple Sclerosis Patients 175
Mutual communication of envelope glycoproteins of paramixoviruses 173
Anomeric specificity and protein-substrate interactions support the 3D model for the hemagglutinin-neuraminidase from Sendai virus 172
Activation of the Sendai virus fusion protein by receptor binding 170
HUMAN ASYMPTOMATIC LEISHMANIA INFANTUM INFECTION. NEW INSIGHTS IN PATIENTS WITH CHRONIC RHEUMATIC DISEASES TREATED WITH BIOLOGICAL AGENTS AND LIVING IN RURAL AREAS OF NORTHERN ITALY 168
Vaginal lactoferrin modulates PGE2, MMP-9, MMP-2, and TIMP-1 amniotic fluid concentrations 167
Transfusion of stored red blood cells in critically ill trauma patients: a retrospective study 163
null 163
Potential relevance of cerebrospinal fluid and serum levels and intrathecal synthesis of active matrix metalloproteinase-2 (MMP-2) as markers of disease remission in patients with multiple sclerosis 161
Antiproliferative effects of novel synthetic nucleobase analogues on U937 Histiocytic lymphoma cell line 160
Affinity labelling of the NADP+-binding site of glucose 6-phosphate dehydrogenase from Candida utilis 159
Affinity distribution of anti-EBV IgG in the cerebrospinal fluid of patients with multiple sclerosis and in controls 158
A proteomic approach to detect gelatinases levels and their inhibitors in patients with neurological diseases 157
Characterization of anti-coagulant properties of prenylated coumarin ferulenol. 156
Le beta-esosaminidasi liquorali in sogetti affetti da sclerosi multipla e in controlli sani 156
Clinical and MRI activity are associated to elevated cerebrospinal fluid and serum levels and intrathecal synthesis of active matrix metalloproteinase-9 in multiple sclerosis patients 153
Serum Gelatinases Levels in Multiple Sclerosis Patients during 21 Months of Natalizumab Therapy 153
Fast skeletal troponin i, but not the slow isoform, is increased in patients under statin therapy: A pilot study 153
Balanced and unbalanced solutions modulate the release of Matrix Metalloproteinase-9 (MMP-9) from neutrophils in response to inflammatory stimuli: an in vitro study 152
Long-term expression of highly differentiated functions by isolated porcine hepatocytes perfused in a radial-flow bioreactor 152
Myelin basic protein inhibits formyl-peptide induced chemotaxis in human neutrophils 150
Lower airways inflammation in patients with ARDS measured using endotracheal aspirates: a pilot study. 150
Cerebrospinal fluid and serum levels and intrathecal production of active matrix metalloproteinase-9 are elevated in in multiple sclerosis patients with disease activity 150
Matrix metalloproteinase-9 activity detected in body fluids is the result of two different enzyme forms 149
Peptides derived from the heptad repeat region near the C-terminal of Sendai virus F protein bind the hemagglutinin-neuraminidase ectodomain 149
Effect of pH on MMP-9 release by LPS-stimulated neutrophils 148
ERMES: EMILIA ROMAGNA MULTIPLE SCLEROSIS. REGIONAL NETWORK FOR IMPLEMENTING A BIOLOGICAL BANK TO IDENTIFY MARKERS OF DISEASE ACTIVITY RELATED TO CLINICAL VARIABLES Identification of a TIMP-1-resistant active MMP-9 in serum of Multiple Sclerosis patients 148
Matrix metalloproteinase-2 (MMP-2) generates soluble HLA-G1 by cell surface proteolytic shedding 148
Analisi della proteina basica della mielina nel liquor 146
Sex difference impacts on the relationship between paraoxonase-1 (Pon1) and type 2 diabetes 146
A Comparison Between Different Anti-Retroviral Therapy Regimes on Soluble Inflammation Markers: a Pilot Study 146
Sex difference: an important issue to consider in epidemiological and clinical studies dealing with serum paraoxonase-1 144
A machine-learning based bio-psycho-social model for the prediction of non-obstructive and obstructive coronary artery disease 143
Increased age and male sex are independently associated with higher frequency of blood-cerebrospinal fluid barrier dysfunction using the albumin quotient 143
Substrate-induced intramolecular proton transfer in 6-phosphogluconate dehydrogenase from Candida utilis 142
Effect of antiglaucoma drops on advanced glycation end-products (AGEs) levels in conjunctival sac fluid 142
Le Metalloproteasi come potenziali marcatori biologici nella Sclerosi Multipla 142
Inhibition of Sendai virus hemagglutinin neuraminidase by the fusion protein 139
Finding peculiar patterns of kinetoplastida enzymes to be exploited in drug design 139
Low Molecular Weight Heparin as inhibitor of gelatinases: possile anti-inflammatory role 139
Conformational transitions during thermal inactivation of the neuraminidase from sendai virus 137
Multiplex Matrix Metalloproteinases Analysis in the Cerebrospinal Fluid Reveals Potential Specific Patterns in Multiple Sclerosis Patients 137
Non-enzymic protein phosphorylation. Phosphorylation of 6-phosphogluconate dehydrogenase by acyl phosphates 136
Analysis of MMP-9 in CSF and sera of patients with neurological diseases 136
The stabilization by a coenzyme analog of a conformational change induced by substrate in 6-phosphogluconate dehydrogenase 135
A Real-Time PCR to Detect Leishmania Infantum DNA in Immunocompetent Patients with Chronic Inflammatory Rheumatisms Living in Rural Areas of Northern Italy and Treated with Biologic Drugs. 135
Mild proteolysis induces a ready-to-fuse state on Sendai virus envelope 134
Elevated CSF and serum levels and intrathecal synthesis of active MMP-2 in MS patients with no evidence of MRI disease activity 134
Testosterone-to-estradiol ratio and platelet thromboxane release in ischemic heart disease: the EVA project 133
Evidence for multiple pairs of vicinal thiols in some proteins 132
A catalytic tyrosine at the active site of sendai virus neuraminidase 131
Thermal stability of the hemagglutinin-neuraminidase from Sendai virus evidences two folding domains 131
Anomeric specificity of the neuraminidase from sendai virus 130
Biochemical study in adult population with stroke in Ferrara, Fabry disease 130
Arylesterase activity of paraoxonase-1 in serum and cerebrospinal fluid of patients with alzheimer’s disease and vascular dementia 129
null 128
Elevato riscontro di DNA circolante di Leishmania infantum in soggetti immunocompetenti affetti da malattie reumatologiche e trattati con farmaci biotecnologici. 128
Characterization of PAR-mediated signaling induced by activated coagulation factor X mutants 127
Development, optimization and validation of an absolute specific assay for active myeloperoxidase (MPO) and its application in a clinical context: Role of MPO specific activity in coronary artery disease 127
Myelin basic protein inhibits the calcium response to phytohaemagglutinin in human lymphocytes 126
The effect of inorganic phosphate on the stability of some enzymes 126
Hydroxyethyl Starch 130/0.4 Binds to Neutrophils Impairing Their Chemotaxis through a Mac-1 Dependent Interaction 126
Limited preotolysis of cHN, the soluble hemagglutinin neuraminidase from sendai virus 125
Decrease Paraoxonase-1 (PON-1) Activities in Neurodegenerative Diseases 124
6-fosfogluconato deidrogenasi da eritrociti umani: interazione con i coenzimi 123
Half-site reactivity in 6-phosphogluconate dehydrogenase from human erythrocytes 123
INTRATHECAL PRODUCTION OF ACTIVE FORM OF MATRIX METALLOPROTEINASES-9 IN PATIENTS WITH MULTIPLE SCLEROSIS: PRELIMINARY RESULTS” 123
Purification of transglutaminase enzyme from Leishmania infantum promastigotes 123
Studies of Interaction between Sendai Virus Envelope Glycoproteins (HN ad F) by Syntetic peptides derived from the HR2 Region of the F Protein 122
Rilevanza delle forme attive delle gelatinasi nel monitoraggio dell'attività della Sclerosi multipla 122
Molecular defects of the glycine 41 variants of alanine glyoxylate aminotransferase associated with primary hyperoxaluria type I 121
SERUM GELATINASES LEVELS IN MULTIPLE SCLEROSIS PATIENTS DURING 21 MONTHS OF NATALIZUMAB TREATMENT 121
Kappa free light chains is a valid tool in the diagnostics of MS: A large multicenter study 119
Preliminary cheracterization of recombinant hemagglutinin from Mumps virus 118
Domain structure of the hemagglutinin-neuraminidase from sendai virus 118
Pain in head and neck cancer patients: The role of gender 117
Biochemical characterization of the natural Cys386-FX variant: a new tool to investigate coagulation factor X functions? 116
Catalytic mechanism of 6-phosphogluconate dehydrogenase investigated by site-directed mutagenesis 115
Caratterizzazione di una proteina del LCS che interagisce con la proteina basica della mielina 115
Matrix metalloproteinases (MMP): determination of different forms by different techniques may require different preanalytical strategies 113
Inflammation and axonal damage biomarkers in Multiple Sclerosis: new perspective on their role 113
Totale 15.240
Categoria #
all - tutte 123.236
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 571
Totale 123.807


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.447 0 0 0 0 0 225 118 267 60 328 332 117
2021/20221.794 79 175 70 62 90 101 51 92 65 183 179 647
2022/20232.132 230 161 54 264 358 297 88 201 244 33 126 76
2023/2024952 98 121 62 25 95 89 25 66 30 23 28 290
2024/20254.210 119 78 375 164 528 329 142 246 650 565 564 450
2025/20266.233 1.119 552 1.168 1.547 1.634 213 0 0 0 0 0 0
Totale 25.182